Concepedia

Marcela V. Maus

MV

Statistics

Publications

121

Citations

21.8K

H-Index

64

Active since

1999

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University of Pennsylvania

Dana-Farber Cancer Institute

Center for Cancer Research

Marcela V. Maus is an author at Massachusetts General Hospital specializing in immunotherapy, immunology, and cancer immunotherapy.

ORCID

Publications per year

1999–2025

121

Publications

121

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai et al. · Science Translational Medicine · 2017 · 1.8K citations · Full text

, , +17

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

, , +17

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus et al. · Blood · 2013 · 1.2K citations

, , +16

Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus et al. · Cancer Immunology Research · 2013 · 860 citations · Full text

, , +17

CD8+ T-cell responses to adeno-associated virus capsid in humans

Federico Mingozzi, Marcela V. Maus, Daniel J. Hui et al. · Nature Medicine · 2007 · 726 citations

, , +14

1–5 of 121